2,224
Views
16
CrossRef citations to date
0
Altmetric
Drug Discovery Case History

An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19)

, , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Pasquale Pagliano, Annamaria Spera, Carmine Sellitto, Giuliana Scarpati, Veronica Folliero, Ornella Piazza, Gianluigi Franci, Valeria Conti & Tiziana Ascione. (2023) Preclinical discovery and development of nirmatrelvir/ritonavir combinational therapy for the treatment of COVID-19 and the lessons learned from SARS-COV-2 variants. Expert Opinion on Drug Discovery 18:12, pages 1301-1311.
Read now
Carmine Sellitto, Graziamaria Corbi, Nicola Bertini, Tiziana Ascione, Maria Costantino, Giuliana Scarpati, Ornella Piazza, Amelia Filippelli, Valeria Conti & Pasquale Pagliano. (2023) Effect of remdesivir on mortality rate and clinical status of COVID-19 patients: a systematic review with meta-analysis. Journal of Chemotherapy 35:5, pages 383-396.
Read now
Pasquale Pagliano, Carmine Sellitto, Tiziana Ascione, Giuliana Scarpati, Veronica Folliero, Ornella Piazza, Gianluigi Franci, Amelia Filippelli & Valeria Conti. (2022) The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19). Expert Opinion on Drug Discovery 17:12, pages 1299-1311.
Read now
Camila B. P. Da Costa, Ana Claudia De Menezes Cruz, Julio Cesar Q Penha, Helena C Castro, Luis E. R. Da Cunha, Norman A Ratcliffe, Rafael Cisne & Francislene Juliana Martins. (2022) Using in vivo animal models for studying SARS-CoV-2. Expert Opinion on Drug Discovery 17:2, pages 121-137.
Read now

Articles from other publishers (12)

Joseph George Samuel, Beutline Malgija, Cheriyan Ebenezer & Rajadurai Vijay Solomon. (2022) Insight into designing of 2-pyridone derivatives for COVID-19 drug discovery - A computational study. Structural Chemistry 34:4, pages 1289-1308.
Crossref
Xincheng Ni, Yinze Han, Renjie Zhou, Yanmei Zhou & Jian Lei. (2023) Structural insights into ribonucleoprotein dissociation by nucleocapsid protein interacting with non-structural protein 3 in SARS-CoV-2. Communications Biology 6:1.
Crossref
Valeria Conti, Graziamaria Corbi, Francesco Sabbatino, Domenico De Pascale, Carmine Sellitto, Berenice Stefanelli, Nicola Bertini, Matteo De Simone, Luigi Liguori, Ilenia Di Paola, Maddalena De Bernardo, Angela Tesse, Nicola Rosa, Pasquale Pagliano & Amelia Filippelli. (2023) Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches. Journal of Personalized Medicine 13:2, pages 334.
Crossref
Lauren Kirkwood‐Johnson & Yusuke Marikawa. (2022) Developmental toxicity of remdesivir, an anti‐COVID ‐19 drug, is implicated by in vitro assays using morphogenetic embryoid bodies of mouse and human pluripotent stem cells . Birth Defects Research 115:2, pages 224-239.
Crossref
Jerzy Jaroszewicz, Justyna Kowalska, Małgorzata Pawłowska, Magdalena Rogalska, Dorota Zarębska-Michaluk, Marta Rorat, Beata Lorenc, Piotr Czupryna, Katarzyna Sikorska, Anna Piekarska, Anna Dworzańska, Izabela Zaleska, Włodzimierz Mazur, Dorota Kozielewicz, Krzysztof Kłos, Regina Podlasin, Grzegorz Angielski, Barbara Oczko-Grzesik, Magdalena Figlerowicz, Bartosz Szetela, Beata Bolewska, Paulina Frańczak-Chmura, Robert Flisiak & Krzysztof Tomasiewicz. (2022) Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy. Cancers 14:19, pages 4720.
Crossref
Daniel Gaviña, Marcos Escolano, Fernando Rabasa‐Alcañiz, Santiago Díaz‐Oltra, María Sánchez‐Roselló & Carlos del Pozo. (2022) Tandem Asymmetric Cycloaromatization/ Intramolecular Pictet‐Spengler‐Type Reaction. An Entry to Polycyclic Pyrroles. Advanced Synthesis & Catalysis 364:17, pages 2982-2988.
Crossref
Giuliana Scarpati & Ornella Piazza. (2022) Comment on Guerrero-Romero et al. Magnesium-to-Calcium Ratio and Mortality from COVID-19. Nutrients 2022, 14, 1686. Nutrients 14:16, pages 3442.
Crossref
Yusuke Marikawa & Vernadeth B. Alarcon. (2022) Remdesivir impairs mouse preimplantation embryo development at therapeutic concentrations. Reproductive Toxicology 111, pages 135-147.
Crossref
Ying Liu, Lu Li, Khalid A. Timani & Johnny J. He. (2022) A Unique Robust Dual-Promoter-Driven and Dual-Reporter-Expressing SARS-CoV-2 Replicon: Construction and Characterization. Viruses 14:5, pages 974.
Crossref
Yuri Kosinsky, Kirill Peskov, Donald R. Stanski, Diana Wetmore & Joseph Vinetz. (2022) Semi-Mechanistic Pharmacokinetic-Pharmacodynamic Model of Camostat Mesylate-Predicted Efficacy against SARS-CoV-2 in COVID-19. Microbiology Spectrum 10:2.
Crossref
Valeria Conti, Carmine Sellitto, Martina Torsiello, Valentina Manzo, Emanuela De Bellis, Berenice Stefanelli, Nicola Bertini, Maria Costantino, Chiara Maci, Emanuel Raschi, Francesco Sabbatino, Graziamaria Corbi, Pasquale Pagliano & Amelia Filippelli. (2022) Identification of Drug Interaction Adverse Events in Patients With COVID-19. JAMA Network Open 5:4, pages e227970.
Crossref
Maria Costantino, Carmine Sellitto, Valeria Conti, Graziamaria Corbi, Francesco Marongiu, Giovanni Genovese, Giuseppina Moccia, Mario Capunzo, Anna Borrelli, Pasquale Pagliano, Mario Farroni, Grazia Maria Lombardi, Maria Giovanna Elberti, Amelia Filippelli & Francesco De Caro. (2022) Adverse Events Associated with BNT162b2 and AZD1222 Vaccines in the Real World: Surveillance Report in a Single Italian Vaccine Center. Journal of Clinical Medicine 11:5, pages 1408.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.